Disease_category,Disease,Protein,Protein_definition,NB_individual,NB_case,HR[95%CI],P_value
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ABCA2,ATP-binding cassette sub-family A member 2,39283,102,2.96 [2.08-4.21],1.7134936506637915e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",45615,120,1.64 [1.39-1.93],4.787922592291903e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ACE2,Angiotensin-converting enzyme 2,45838,124,1.87 [1.50-2.34],3.6280445566353874e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ACP5,Tartrate-resistant acid phosphatase type 5,46891,128,2.88 [2.13-3.89],7.504689207218237e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ACTA2,"Actin, aortic smooth muscle",45838,124,2.21 [1.83-2.67],1.3548336717330802e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ACTN2,Alpha-actinin-2,39283,102,1.64 [1.28-2.08],6.759316565702853e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ACVRL1,Serine/threonine-protein kinase receptor R3,46258,124,6.80 [4.95-9.35],2.7564297449054244e-32
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ACY1,Aminoacylase-1,46694,125,1.91 [1.53-2.38],8.344806375970616e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,39283,102,2.13 [1.62-2.81],8.541176115711388e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ADA2,Adenosine deaminase 2,46431,124,6.29 [4.90-8.07],3.1497180253023576e-47
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,47039,128,2.77 [1.92-4.00],5.6740633650179735e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,40451,106,4.70 [3.40-6.50],8.414995659179207e-21
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,39446,103,2.43 [1.79-3.31],1.5741846844600653e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,46483,124,2.74 [1.92-3.91],2.6860688062710512e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ADAMTSL2,ADAMTS-like protein 2,40614,105,6.51 [4.80-8.84],2.769314286405118e-33
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ADGRB3,Adhesion G protein-coupled receptor B3,46258,124,3.33 [2.13-5.21],1.3638209714264457e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ADGRD1,Adhesion G-protein coupled receptor D1,39729,105,2.67 [1.77-4.05],3.274469772605767e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ADGRE1,Adhesion G protein-coupled receptor E1,40451,106,2.10 [1.57-2.82],6.218760458445979e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ADGRE2,Adhesion G protein-coupled receptor E2,46900,124,7.64 [4.95-11.80],4.543842996358484e-20
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ADGRE5,Adhesion G protein-coupled receptor E5,47034,127,4.33 [3.40-5.50],8.387573729207301e-33
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ADGRG1,Adhesion G-protein coupled receptor G1,46483,124,2.31 [2.03-2.63],9.333356486667236e-38
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ADGRG2,Adhesion G-protein coupled receptor G2,46694,125,0.40 [0.31-0.51],1.4065629738123297e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ADM,Pro-adrenomedullin,47097,128,30.78 [16.91-56.04],3.646023820412472e-29
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AFP,Alpha-fetoprotein,46184,124,0.58 [0.44-0.75],5.064908203471218e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AGR2,Anterior gradient protein 2 homolog,45260,123,2.01 [1.76-2.29],3.189200419827461e-25
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AGR3,Anterior gradient protein 3,45538,120,1.56 [1.26-1.95],6.740562773102053e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AGRN,Agrin,46900,124,3.95 [3.23-4.84],1.770982298178391e-40
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AGRP,Agouti-related protein,47210,127,2.58 [1.99-3.36],1.6433033421137622e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AGXT,Serine--pyruvate aminotransferase,46694,125,1.64 [1.36-1.97],1.870832203925515e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AKR1B10,Aldo-keto reductase family 1 member B10,39492,104,1.55 [1.26-1.91],2.924938416873456e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ALCAM,CD166 antigen,47267,128,12.99 [6.97-24.23],7.25539022931015e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AMBP,Protein AMBP,47028,128,25.64 [14.56-45.15],2.67958595202354e-29
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AMIGO2,Amphoterin-induced protein 2,46483,124,5.38 [3.05-9.51],6.583819710997586e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ANG,Angiogenin,46575,125,2.56 [1.77-3.70],6.725281168636901e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ANGPT2,Angiopoietin-2,47097,128,5.57 [4.07-7.64],1.0872288556707303e-26
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ANGPTL1,Angiopoietin-related protein 1,46024,125,4.66 [2.76-7.86],7.862715874901394e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ANGPTL4,Angiopoietin-related protein 4,46823,124,5.19 [3.70-7.29],1.884306989010535e-21
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ANGPTL7,Angiopoietin-related protein 7,47097,128,3.47 [2.63-4.59],2.423050037061432e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ANXA10,Annexin A10,45638,124,1.50 [1.28-1.75],3.73664450333707e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AOC3,Membrane primary amine oxidase,46888,125,11.86 [7.95-17.71],1.0120476451933348e-33
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,APLP1,Amyloid-like protein 1,46694,125,0.49 [0.36-0.68],1.3948078132638366e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,APOA4,Apolipoprotein A-IV,40679,105,3.44 [2.73-4.33],8.475119795829328e-26
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,APOC1,Apolipoprotein C-I,40604,105,0.49 [0.37-0.65],9.4659521840646e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,APOF,Apolipoprotein F,40646,105,0.40 [0.30-0.55],1.1595777403980056e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,APOM,Apolipoprotein M,46810,125,0.31 [0.23-0.43],1.4669012828648814e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AREG,Amphiregulin,46483,124,4.59 [3.79-5.56],3.794844061776064e-55
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ASGR1,Asialoglycoprotein receptor 1,46337,124,7.06 [5.34-9.32],4.1765944585458445e-43
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ASGR2,Asialoglycoprotein receptor 2,40646,105,6.52 [3.67-11.61],1.734319231253926e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ATP6AP2,Renin receptor,45615,120,1.84 [1.43-2.36],1.7798189273824443e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ATRAID,All-trans retinoic acid-induced differentiation factor,40451,106,1.79 [1.49-2.15],3.2339503196872184e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AXL,Tyrosine-protein kinase receptor UFO,46888,125,4.08 [2.44-6.81],8.393901681114093e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,B2M,Beta-2-microglobulin,40679,105,2.00 [1.72-2.32],5.479199834709823e-20
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",39538,103,8.82 [5.68-13.72],3.913955064795973e-22
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,B4GALT1,"Beta-1,4-galactosyltransferase 1",46900,124,8.58 [5.54-13.28],6.054543265832248e-22
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,45615,120,1.83 [1.53-2.19],2.491846688184929e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BAMBI,BMP and activin membrane-bound inhibitor homolog,45615,120,3.65 [2.80-4.76],1.6324633357594969e-21
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BCAM,Basal cell adhesion molecule,46698,127,3.26 [2.17-4.90],1.2925686764754892e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BCAN,Brevican core protein,46337,124,0.37 [0.29-0.48],4.990643357057713e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",46626,123,2.54 [1.63-3.96],3.98564555702783e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BMPER,BMP-binding endothelial regulator protein,39729,105,7.45 [5.21-10.64],3.306547417174873e-28
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,39446,103,2.21 [1.60-3.06],1.6638565431787505e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BOC,Brother of CDO,45838,124,6.97 [3.92-12.41],3.929371893761431e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BSG,Basigin,47133,127,8.14 [4.57-14.49],1.0466684555763076e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BST1,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,47117,128,2.87 [1.69-4.88],9.952624595861854e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BST2,Bone marrow stromal antigen 2,47117,128,1.62 [1.30-2.02],1.7609437278323296e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BTN2A1,Butyrophilin subfamily 2 member A1,46900,124,6.98 [4.99-9.77],9.53963268525568e-30
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BTN3A2,Butyrophilin subfamily 3 member A2,46626,123,2.22 [1.79-2.76],4.3348191960439723e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,C1QA,Complement C1q subcomponent subunit A,46978,126,4.99 [2.84-8.76],2.1052480192053653e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,46888,125,3.03 [2.38-3.86],2.344394266990342e-19
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,C2,Complement C2,46810,125,7.18 [3.40-15.19],2.471911242932267e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,C7,Complement component C7,39701,103,12.09 [8.34-17.52],1.4363331256049084e-39
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CA12,Carbonic anhydrase 12,46483,124,4.64 [3.70-5.81],9.061252771950735e-41
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CA5A,"Carbonic anhydrase 5A, mitochondrial",45838,124,1.44 [1.24-1.67],2.0368502328889054e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CA6,Carbonic anhydrase 6,46560,127,0.52 [0.40-0.66],2.0160085039777585e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CA9,Carbonic anhydrase 9,47097,128,2.43 [1.87-3.16],2.983952952113179e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CALCA,Calcitonin,46261,123,1.77 [1.49-2.10],9.762671870659759e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CANT1,Soluble calcium-activated nucleotidase 1,46556,125,8.68 [4.26-17.68],2.5868052552038795e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CARHSP1,Calcium-regulated heat-stable protein 1,45638,124,0.50 [0.36-0.71],7.543347595686249e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CBLIF,Cobalamin binding intrinsic factor,46621,125,1.62 [1.33-1.97],2.015502144523894e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CCDC80,Coiled-coil domain-containing protein 80,46694,125,2.69 [1.91-3.78],1.3878888380520637e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CCL11,Eotaxin,47210,127,3.55 [2.34-5.39],2.654459345306535e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CCL14,C-C motif chemokine 14,46575,125,1.92 [1.48-2.50],1.0155165294595556e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CCL15,C-C motif chemokine 15,47267,128,4.12 [3.12-5.45],1.652791559330117e-23
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CCL16,C-C motif chemokine 16,47267,128,2.61 [1.92-3.54],9.62648476363658e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CCL20,C-C motif chemokine 20,47210,127,1.55 [1.37-1.75],1.1794106584207417e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CCL21,C-C motif chemokine 21,46900,124,2.18 [1.80-2.64],3.129418638705856e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CCL25,C-C motif chemokine 25,47210,127,2.70 [1.99-3.65],1.2791530778826535e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CCL3,C-C motif chemokine 3,46626,123,1.42 [1.23-1.65],2.0845083521939383e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CCL7,C-C motif chemokine 7,46626,123,1.70 [1.44-2.01],3.060039388109754e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CCN3,CCN family member 3,47196,128,3.50 [2.59-4.74],4.051331507319435e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CCN4,CCN family member 4,47097,128,3.35 [2.49-4.51],1.5555119686925797e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CCN5,CCN family member 5,46698,127,3.31 [2.31-4.74],6.392550784150883e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CCS,Copper chaperone for superoxide dismutase,46337,124,0.41 [0.29-0.59],1.937491976501768e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD109,CD109 antigen,46698,127,4.12 [2.60-6.52],1.632045376571848e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD14,Monocyte differentiation antigen CD14,45736,125,3.25 [2.39-4.43],7.498895840945535e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD160,CD160 antigen,47210,127,3.12 [2.43-4.01],3.993878084574971e-19
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD163,Scavenger receptor cysteine-rich type 1 protein M130,46888,125,2.75 [2.01-3.76],1.9305853559824084e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD164,Sialomucin core protein 24,46698,127,1.76 [1.46-2.13],4.85291198352942e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD207,C-type lectin domain family 4 member K,45679,121,3.52 [2.40-5.16],1.338431560706963e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD22,B-cell receptor CD22,47210,127,1.82 [1.35-2.46],9.9898398548864e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD244,Natural killer cell receptor 2B4,47210,127,4.57 [2.85-7.33],2.722119391504789e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD27,CD27 antigen,46850,129,4.32 [3.55-5.26],2.4272903399433352e-48
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD274,Programmed cell death 1 ligand 1,46337,124,3.79 [2.89-4.96],3.7140224623955613e-22
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD276,CD276 antigen,46670,123,11.16 [7.85-15.86],3.317356283533556e-41
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD28,T-cell-specific surface glycoprotein CD28,45615,120,2.80 [2.29-3.41],5.121848574648335e-24
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD300A,CMRF35-like molecule 8,39729,105,6.46 [4.01-10.43],2.009274390458337e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD300C,CMRF35-like molecule 6,47117,128,4.21 [3.05-5.81],2.184481533643953e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD300E,CMRF35-like molecule 2,46946,127,4.13 [3.12-5.47],3.6589309164074896e-23
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD300LF,CMRF35-like molecule 1,47097,128,2.01 [1.50-2.70],3.657173139719557e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD302,CD302 antigen,46483,124,5.77 [4.50-7.39],1.5835880408540182e-43
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,46483,124,5.06 [3.39-7.55],2.284157089346856e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD40,Tumor necrosis factor receptor superfamily member 5,46668,124,2.25 [1.73-2.93],1.252182353203624e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD46,Membrane cofactor protein,46428,125,4.20 [2.97-5.95],5.51392774432506e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD48,CD48 antigen,46823,124,6.28 [4.38-8.99],1.155326184639097e-23
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD5,T-cell surface glycoprotein CD5,47028,128,2.35 [1.97-2.81],1.872850211106139e-21
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD55,Complement decay-accelerating factor,45075,119,3.71 [2.70-5.10],7.485935424649421e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD59,CD59 glycoprotein,45016,122,6.12 [4.43-8.47],7.941478825815839e-28
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD7,T-cell antigen CD7,39374,102,2.67 [2.02-3.52],3.814204293516689e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD70,CD70 antigen,46626,123,2.42 [1.82-3.21],9.80449182302916e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD72,B-cell differentiation antigen CD72,39729,105,2.48 [1.84-3.35],2.343434819520022e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD74,HLA class II histocompatibility antigen gamma chain,47117,128,7.04 [5.08-9.74],6.122640835514551e-32
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD79B,B-cell antigen receptor complex-associated protein beta chain,47210,127,3.04 [2.50-3.70],4.2771936427676965e-29
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD80,T-lymphocyte activation antigen CD80,40628,107,4.56 [3.36-6.19],1.7223952865181611e-22
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD83,CD83 antigen,46626,123,4.41 [3.34-5.83],2.2213955326867937e-25
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD8A,T-cell surface glycoprotein CD8 alpha chain,47117,128,1.99 [1.55-2.55],5.1271742542341486e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD93,Complement component C1q receptor,44916,119,2.86 [1.78-4.59],1.479826723004158e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD99,CD99 antigen,46698,127,6.68 [3.81-11.73],3.5539569656007544e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD99L2,CD99 antigen-like protein 2,46698,127,3.44 [1.89-6.28],5.622879028666308e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CDCP1,CUB domain-containing protein 1,46337,124,2.69 [2.17-3.32],6.209739883992403e-20
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CDH1,Cadherin-1,45157,120,2.62 [2.18-3.13],1.826558122987095e-25
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CDH15,Cadherin-15,47041,127,1.66 [1.39-1.98],1.536599841153002e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CDH17,Cadherin-17,46694,125,2.12 [1.75-2.57],3.364658970372695e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CDH2,Cadherin-2,46694,125,5.60 [3.66-8.58],2.299060907437496e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CDH3,Cadherin-3,47117,128,2.79 [1.95-3.98],1.7040231680119315e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CDH6,Cadherin-6,46694,125,3.01 [2.22-4.07],1.375600497186241e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CDNF,Cerebral dopamine neurotrophic factor,46483,124,1.90 [1.40-2.59],4.23896943067798e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,40451,106,2.23 [1.56-3.20],1.325624956233588e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,45017,118,1.73 [1.39-2.16],1.2375488824504029e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,40614,105,1.89 [1.50-2.38],4.852684171319902e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,45838,124,1.83 [1.40-2.40],1.296336222668096e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CES2,Cocaine esterase,46483,124,1.69 [1.33-2.15],2.0846287607584467e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CFC1,Cryptic protein,45615,120,2.21 [1.75-2.78],2.0298527823631093e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CFD,Complement factor D,40679,105,4.08 [2.57-6.48],2.610993786729857e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CGA,Glycoprotein hormones alpha chain,46698,127,1.88 [1.53-2.30],1.212229219712304e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CGREF1,Cell growth regulator with EF hand domain protein 1,46694,125,3.94 [2.83-5.49],4.519577291194125e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CHAD,Chondroadherin,39729,105,0.51 [0.42-0.64],8.194090045233885e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",40529,106,3.08 [2.58-3.67],6.219769466294398e-36
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CHCHD6,MICOS complex subunit MIC25,40433,105,2.87 [2.15-3.82],5.289789895329107e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CHGA,Chromogranin-A,40614,105,1.79 [1.57-2.04],1.3914203628289257e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CHGB,Secretogranin-1,46967,127,2.56 [1.85-3.53],1.189161067397408e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CHI3L1,Chitinase-3-like protein 1,45685,121,1.98 [1.71-2.29],1.3702705529416942e-19
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CHRDL1,Chordin-like protein 1,46823,124,5.15 [3.34-7.93],1.0229280300192205e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CILP,Cartilage intermediate layer protein 1,40614,105,3.52 [2.80-4.43],3.243642627621925e-27
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CKAP4,Cytoskeleton-associated protein 4,46978,127,4.89 [3.90-6.14],8.404840143141878e-43
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CLEC10A,C-type lectin domain family 10 member A,46337,124,2.70 [1.74-4.20],1.0528132785279786e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CLEC12A,C-type lectin domain family 12 member A,39446,103,3.03 [1.75-5.24],7.793585381613919e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CLEC14A,C-type lectin domain family 14 member A,46698,127,4.09 [2.75-6.09],3.718933465516456e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CLEC1A,C-type lectin domain family 1 member A,45838,124,3.46 [2.35-5.10],3.4399166772525576e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CLEC3B,Tetranectin,39735,105,0.33 [0.20-0.55],2.013302723012984e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CLEC4A,C-type lectin domain family 4 member A,46626,123,0.36 [0.25-0.53],1.4494055818158521e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CLEC4D,C-type lectin domain family 4 member D,46626,123,2.01 [1.60-2.52],1.2758842113839975e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CLEC5A,C-type lectin domain family 5 member A,46538,125,3.82 [2.48-5.87],1.0741673069442747e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CLEC6A,C-type lectin domain family 6 member A,45615,120,2.67 [2.02-3.52],5.514065306843622e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CLEC7A,C-type lectin domain family 7 member A,47210,127,2.24 [1.61-3.13],2.034649322837968e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CLGN,Calmegin,39492,104,1.92 [1.51-2.45],1.346839793283906e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CLMP,CXADR-like membrane protein,47097,128,8.19 [5.10-13.16],3.260865112389615e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CLSTN2,Calsyntenin-2,47210,127,2.99 [2.34-3.81],8.637475722460147e-19
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CLSTN3,Calsyntenin-3,40529,106,2.83 [1.78-4.50],1.039135501336566e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CLUL1,Clusterin-like protein 1,46620,125,0.42 [0.30-0.60],2.172467625411096e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CNTN2,Contactin-2,47097,128,2.14 [1.53-2.99],8.700106391913264e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CNTN4,Contactin-4,46698,127,3.90 [2.09-7.29],1.949069348308644e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CNTN5,Contactin-5,46822,126,0.37 [0.24-0.57],8.184822142269484e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CNTNAP2,Contactin-associated protein-like 2,46626,123,2.30 [1.71-3.08],2.8749796806807343e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,COL18A1,Collagen alpha-1(XVIII) chain,46891,127,17.94 [10.52-30.58],2.770814705698849e-26
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,COL3A1,Collagen alpha-1(III) chain,40614,105,3.96 [2.12-7.39],1.6280088979229814e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,COL4A1,Collagen alpha-1(IV) chain,46694,125,4.37 [3.15-6.06],9.229225122317784e-19
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,COL5A1,Collagen alpha-1(V) chain,39729,105,2.90 [2.11-3.97],4.437037522493543e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,COL6A3,Collagen alpha-3(VI) chain,47267,128,5.12 [3.94-6.66],2.396938739713512e-34
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,COLEC12,Collectin-12,46670,123,9.66 [6.63-14.08],4.2205674742699365e-32
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CPA2,Carboxypeptidase A2,46961,127,2.06 [1.68-2.54],9.147716231610136e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CPM,Carboxypeptidase M,46893,127,5.75 [4.03-8.21],6.663665865452723e-22
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CPXM2,Inactive carboxypeptidase-like protein X2,40628,107,4.57 [3.29-6.35],1.2637177829126113e-19
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CR1,Complement receptor type 1,40490,105,2.90 [2.14-3.94],8.344435673583283e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CR2,Complement receptor type 2,46888,125,2.42 [1.78-3.29],1.7961560932702082e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CRELD1,Protein disulfide isomerase CRELD1,39729,105,5.59 [3.53-8.87],2.539926365692515e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CRELD2,Protein disulfide isomerase CRELD2,46823,124,2.16 [1.65-2.82],1.8392208357661522e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CRH,Corticoliberin,45538,119,0.63 [0.51-0.76],4.519157442468347e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CRHBP,Corticotropin-releasing factor-binding protein,46670,123,8.44 [4.90-14.55],1.5725106753999186e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CRIM1,Cysteine-rich motor neuron 1 protein,46900,124,11.22 [5.98-21.05],5.0201726812663125e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CRIP2,Cysteine-rich protein 2,46337,124,2.17 [1.78-2.64],1.4289367605734137e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CRLF1,Cytokine receptor-like factor 1,46900,124,3.67 [2.00-6.73],2.7106867814382662e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CRTAM,Cytotoxic and regulatory T-cell molecule,46337,124,2.06 [1.52-2.80],3.779807867535272e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CSF1,Macrophage colony-stimulating factor 1,46900,124,11.01 [6.95-17.43],1.6151784013520003e-24
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CSF1R,Macrophage colony-stimulating factor 1 receptor,40646,105,2.87 [2.05-4.02],8.720304377559162e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,46337,124,1.58 [1.28-1.96],2.7932077600891268e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CSRP3,Cysteine and glycine-rich protein 3,39283,102,1.43 [1.26-1.63],7.038293776703668e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CST3,Cystatin-C,46819,125,6.73 [4.79-9.45],3.042775054633414e-28
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CST7,Cystatin-F,46745,124,1.34 [1.19-1.50],1.0188598904355525e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CSTB,Cystatin-B,46044,121,2.34 [1.73-3.17],4.09037859706804e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CTHRC1,Collagen triple helix repeat-containing protein 1,40614,105,3.94 [2.49-6.23],4.250716157109641e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CTRC,Chymotrypsin-C,46668,123,0.61 [0.48-0.77],4.692814372431126e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CTRL,Chymotrypsin-like protease CTRL-1,40529,106,0.58 [0.45-0.75],2.4501129237422025e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CTSD,Cathepsin D,43631,114,2.83 [2.28-3.51],4.15748238369954e-21
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CTSE,Cathepsin E,39729,105,2.09 [1.48-2.95],2.6513607820582364e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CTSL,Cathepsin L1,46694,125,7.87 [4.60-13.46],5.2260896453705485e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CTSO,Cathepsin O,47210,127,4.34 [3.06-6.16],1.741932459737473e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CTSS,Cathepsin S,36692,100,13.08 [6.78-25.24],1.7593233476915663e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CTSZ,Cathepsin Z,46737,125,6.36 [4.11-9.83],1.0067909841921902e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CX3CL1,Fractalkine,46337,124,2.57 [1.72-3.83],3.508334351756273e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CXADR,Coxsackievirus and adenovirus receptor,46626,123,2.12 [1.65-2.74],5.449781783784434e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CXCL13,C-X-C motif chemokine 13,47117,128,1.43 [1.26-1.62],1.12647912013591e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CXCL16,C-X-C motif chemokine 16,47187,128,5.52 [3.11-9.79],5.241807859855444e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CXCL17,C-X-C motif chemokine 17,47210,127,1.81 [1.37-2.39],2.864072856153764e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CXCL8,Interleukin-8,46351,127,1.42 [1.22-1.65],5.8742196440592975e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CXCL9,C-X-C motif chemokine 9,46900,124,1.72 [1.42-2.08],2.9047197352962734e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DAG1,Dystroglycan,46900,124,2.24 [1.62-3.08],8.225219372546324e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",46850,129,4.91 [3.77-6.38],1.6195553156956123e-32
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DCN,Decorin,45838,124,7.10 [4.19-12.01],2.902738371362885e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",46483,124,2.49 [1.89-3.28],6.968257776629859e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DDR1,Epithelial discoidin domain-containing receptor 1,47117,128,7.07 [4.37-11.42],1.4436410723199405e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DEFA1_DEFA1B,Neutrophil defensin 1,45757,124,1.88 [1.56-2.28],4.5846437157642285e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DEFB103A_DEFB103B,Beta-defensin 103,39143,103,1.80 [1.46-2.23],6.370993903058932e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DEFB4A_DEFB4B,Beta-defensin 4A,46025,124,1.26 [1.13-1.41],2.467111424714752e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DKK3,Dickkopf-related protein 3,47267,128,3.08 [1.85-5.14],1.5500901011962692e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DKK4,Dickkopf-related protein 4,46259,124,3.03 [2.48-3.69],1.1599970697212506e-27
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DLL1,Delta-like protein 1,46850,129,9.16 [6.62-12.69],1.1863497610489595e-40
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DMD,Dystrophin,39538,103,1.81 [1.46-2.25],5.269600050693437e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DMP1,Dentin matrix acidic phosphoprotein 1,39538,103,0.38 [0.32-0.46],6.234596605412658e-26
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DNM3,Dynamin-3,40550,105,1.80 [1.45-2.25],1.504469415186715e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DPP10,Inactive dipeptidyl peptidase 10,46626,123,2.15 [1.53-3.03],1.1313840610548432e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DPP6,Dipeptidyl aminopeptidase-like protein 6,46483,124,4.17 [2.74-6.33],2.1999416480375448e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DPT,Dermatopontin,47267,128,9.11 [4.60-18.03],2.302075941057673e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DPY30,Protein dpy-30 homolog,46950,128,1.98 [1.66-2.37],5.3084968916000754e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DRAXIN,Draxin,46337,124,2.38 [1.76-3.20],1.255302568253083e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DSC2,Desmocollin-2,46177,126,5.16 [4.03-6.61],1.9011427311598511e-38
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DSCAM,Down syndrome cell adhesion molecule,40550,105,3.69 [2.27-5.99],1.2569681915031634e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DSG4,Desmoglein-4,46338,123,0.46 [0.34-0.62],5.611265690941601e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DTNB,Dystrobrevin beta,40358,105,3.37 [2.64-4.29],8.657627561977511e-23
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DTX3,Probable E3 ubiquitin-protein ligase DTX3,46483,124,2.58 [1.66-3.99],2.3353922973983464e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EBI3_IL27,Interleukin-27,47029,128,4.81 [3.20-7.21],3.383264456026217e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EDA2R,Tumor necrosis factor receptor superfamily member 27,47097,128,5.38 [4.36-6.64],3.353465051538588e-55
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,45838,124,2.55 [1.77-3.68],5.40646538256138e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EDN1,Endothelin-1,39538,103,5.84 [3.66-9.30],1.1133002878520469e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EFCAB14,EF-hand calcium-binding domain-containing protein 14,40451,106,2.01 [1.57-2.57],3.495096030187229e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,46809,125,7.70 [5.25-11.30],1.6151961705734324e-25
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EFNA1,Ephrin-A1,46618,126,6.47 [4.83-8.67],4.816016223349088e-36
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EGFL7,Epidermal growth factor-like protein 7,45615,120,2.04 [1.53-2.71],1.1319027505273188e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ELN,Elastin,40628,107,3.52 [2.14-5.81],8.036172000956755e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ENAH,Protein enabled homolog,45833,124,1.91 [1.46-2.48],1.682283958211763e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ENG,Endoglin,47267,128,4.56 [2.17-9.59],6.247989444037537e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,47267,128,3.62 [2.20-5.96],3.825850274913776e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EP300,Histone acetyltransferase p300,39446,103,1.96 [1.43-2.69],3.124879852829229e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EPHA1,Ephrin type-A receptor 1,46824,124,3.69 [2.24-6.10],3.231605676157862e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EPHA2,Ephrin type-A receptor 2,45016,122,4.08 [3.41-4.87],4.04223627185639e-54
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EPHB4,Ephrin type-B receptor 4,47267,128,8.27 [5.66-12.08],9.55664045346816e-28
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EPHB6,Ephrin type-B receptor 6,46261,123,4.09 [2.77-6.05],1.639854020347238e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EPO,Erythropoietin,46626,123,1.41 [1.24-1.61],3.005082337152044e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,47018,128,3.57 [2.63-4.84],3.279609508516541e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ERBB4,Receptor tyrosine-protein kinase erbB-4,46850,129,3.63 [1.95-6.74],4.534805020860058e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ERMAP,Erythroid membrane-associated protein,39446,103,3.10 [2.13-4.50],2.915355300318571e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ESAM,Endothelial cell-selective adhesion molecule,47267,128,4.41 [3.02-6.42],1.2404178264276988e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,F11R,Junctional adhesion molecule A,46698,127,1.70 [1.31-2.19],4.9523820472249535e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,F2R,Proteinase-activated receptor 1,46823,124,2.01 [1.53-2.63],5.357236478239403e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,F9,Coagulation factor IX,46810,125,6.74 [3.06-14.83],2.160827923465456e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FABP1,"Fatty acid-binding protein, liver",46670,123,1.91 [1.68-2.19],8.28393426644526e-22
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FABP4,"Fatty acid-binding protein, adipocyte",47267,128,3.43 [2.81-4.18],5.5696437797208245e-34
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FAM20A,Pseudokinase FAM20A,40628,107,3.16 [2.13-4.68],9.882275801289668e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FAM3B,Protein FAM3B,46483,124,10.31 [6.42-16.54],4.039749814517349e-22
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FAM3C,Protein FAM3C,46621,125,13.03 [9.31-18.24],1.1151368828277048e-50
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FAM3D,Protein FAM3D,40451,106,2.80 [2.23-3.51],4.897826220948484e-19
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FAS,Tumor necrosis factor receptor superfamily member 6,47110,128,1.99 [1.60-2.48],9.50953347696179e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FBLN2,Fibulin-2,40614,105,4.77 [3.08-7.38],2.351024510606341e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,40628,107,1.92 [1.52-2.43],5.1971014210549144e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FCAR,Immunoglobulin alpha Fc receptor,46626,123,2.30 [1.66-3.18],4.7252472944070134e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FCER2,Low affinity immunoglobulin epsilon Fc receptor,46698,127,1.58 [1.28-1.95],2.1564037187582107e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,46498,125,2.11 [1.51-2.94],1.0603914949821903e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FCN1,Ficolin-1,40567,105,3.26 [2.21-4.82],2.576245219663293e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FCRL2,Fc receptor-like protein 2,46985,125,1.80 [1.42-2.27],9.02294880538632e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FCRL6,Fc receptor-like protein 6,46626,123,1.61 [1.28-2.02],3.989901634857977e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FCRLB,Fc receptor-like B,45615,120,1.53 [1.32-1.76],6.1552446999983165e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FDX1,"Adrenodoxin, mitochondrial",39283,102,1.54 [1.28-1.87],8.440197061145587e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FGF21,Fibroblast growth factor 21,47029,128,1.53 [1.37-1.71],2.0502937522158635e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FGF23,Fibroblast growth factor 23,47027,128,1.83 [1.59-2.11],1.2630344419693324e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FGF5,Fibroblast growth factor 5,45833,124,3.60 [2.82-4.59],4.865669484999655e-25
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FGFBP1,Fibroblast growth factor-binding protein 1,46850,129,0.32 [0.24-0.41],2.3336349173797866e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FGFBP2,Fibroblast growth factor-binding protein 2,40614,105,0.38 [0.26-0.55],2.152147976100701e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FGFR2,Fibroblast growth factor receptor 2,46850,129,11.48 [7.53-17.49],6.409192563999904e-30
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FGL1,Fibrinogen-like protein 1,40646,105,2.37 [1.86-3.02],2.2705365979490087e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,46337,124,4.63 [3.06-7.01],4.724316508374363e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FOLR1,Folate receptor alpha,46635,129,3.48 [2.60-4.65],5.1507313180801507e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FSTL1,Follistatin-related protein 1,39538,103,6.09 [3.79-9.78],8.464311526324213e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FSTL3,Follistatin-related protein 3,46592,123,8.04 [5.99-10.78],7.272451841167429e-44
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,46483,124,4.96 [3.10-7.96],2.836578799173816e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,45833,124,1.96 [1.46-2.63],8.482814153444895e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GAST,Gastrin,40529,106,1.44 [1.30-1.59],1.2693430372206457e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GCG,Pro-glucagon,45615,120,1.94 [1.70-2.21],4.6954566036380093e-23
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",46483,124,4.17 [2.77-6.28],7.660490352552645e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GDF15,Growth/differentiation factor 15,47267,128,3.59 [3.19-4.04],5.714762320519955e-98
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GDNF,Glial cell line-derived neurotrophic factor,45638,124,2.47 [1.81-3.36],8.473196902092569e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GFRA1,GDNF family receptor alpha-1,47029,128,12.25 [8.62-17.39],1.7755157879345446e-44
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GGT1,Glutathione hydrolase 1 proenzyme,46618,126,1.92 [1.50-2.45],1.897829930447778e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GIP,Gastric inhibitory polypeptide,39538,103,1.99 [1.51-2.63],9.131111691468412e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GIPC2,PDZ domain-containing protein GIPC2,40529,106,4.92 [3.46-7.00],8.29814748907939e-19
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GLA,Alpha-galactosidase A,39655,104,2.56 [1.69-3.89],9.958383364151691e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GM2A,Ganglioside GM2 activator,39621,104,1.87 [1.56-2.24],1.1170760785765464e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GOLM2,Protein GOLM2,47117,128,6.05 [4.02-9.10],5.78973535016697e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GPA33,Cell surface A33 antigen,46483,124,0.76 [0.67-0.86],7.766173908764032e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GPC5,Glypican-5,46337,124,0.57 [0.43-0.75],7.095198573733095e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GPD1,Glycerol-3-phosphate dehydrogenase,40433,105,1.87 [1.41-2.48],1.5702510852487468e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GPNMB,Transmembrane glycoprotein NMB,45423,120,7.10 [4.28-11.79],3.550250844072318e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GPR15L,Protein GPR15L,40451,106,1.82 [1.39-2.37],1.0386237480346428e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GPR37,Prosaposin receptor GPR37,45838,124,3.47 [2.84-4.25],9.423128313888756e-34
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GPRC5C,G-protein coupled receptor family C group 5 member C,40433,105,1.75 [1.45-2.11],6.762665049404709e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GRN,Progranulin,46467,126,5.76 [3.89-8.53],2.788382635599556e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GRPEL1,"GrpE protein homolog 1, mitochondrial",46483,124,2.22 [1.87-2.64],2.437204570708852e-19
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GSN,Gelsolin,40489,104,6.37 [3.84-10.58],8.09802913140458e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GUCA2A,Guanylin,46464,127,3.99 [2.97-5.37],5.371784801306187e-20
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HAO1,Hydroxyacid oxidase 1,47097,128,1.33 [1.18-1.50],2.86712865435243e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HAVCR1,Hepatitis A virus cellular receptor 1,47028,128,3.10 [2.67-3.59],1.8492046369270072e-51
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HAVCR2,Hepatitis A virus cellular receptor 2,46698,127,4.69 [3.54-6.23],8.283466973532716e-27
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HBQ1,Hemoglobin subunit theta-1,47097,128,0.55 [0.42-0.73],3.625310709287563e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HEG1,Protein HEG homolog 1,39729,105,4.69 [2.52-8.71],1.0210512640758506e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HEPH,Hephaestin,40628,107,8.87 [4.40-17.88],1.0333608272139887e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HGF,Hepatocyte growth factor,47210,127,3.71 [2.67-5.16],6.353486026355903e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HIP1R,Huntingtin-interacting protein 1-related protein,40450,105,2.10 [1.74-2.52],3.032722759640179e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HJV,Hemojuvelin,40550,105,1.74 [1.37-2.21],4.494629434392948e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HLA-E,"HLA class I histocompatibility antigen, alpha chain E",46626,123,5.39 [3.83-7.59],5.689537772302103e-22
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HNMT,Histamine N-methyltransferase,46113,123,2.18 [1.65-2.88],4.9534938278377444e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HPGDS,Hematopoietic prostaglandin D synthase,45615,120,0.34 [0.22-0.53],1.1209086651893044e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,39446,103,3.14 [2.09-4.72],3.9173648206096296e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HSPA2,Heat shock-related 70 kDa protein 2,40433,105,1.92 [1.54-2.39],4.917534404138909e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HSPB6,Heat shock protein beta-6,47097,128,5.35 [4.02-7.12],1.8535197606309707e-30
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,46350,123,5.02 [3.66-6.89],1.6471229660808524e-23
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HYAL1,Hyaluronidase-1,46447,121,6.73 [3.98-11.40],1.2297430359097288e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HYOU1,Hypoxia up-regulated protein 1,47267,128,8.23 [4.51-15.01],5.994096859188196e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ICAM1,Intercellular adhesion molecule 1,46502,124,3.84 [2.41-6.12],1.3607588009785804e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ICAM2,Intercellular adhesion molecule 2,47267,128,3.35 [2.02-5.53],2.448186712842006e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ICAM3,Intercellular adhesion molecule 3,47267,128,3.34 [2.01-5.53],2.8805990912552616e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IDUA,Alpha-L-iduronidase,47097,128,3.38 [2.35-4.87],6.51123318769257e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,39482,103,2.96 [2.07-4.22],2.152190164641403e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IFNGR1,Interferon gamma receptor 1,46900,124,3.41 [2.47-4.72],1.1151456651787217e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IFNGR2,Interferon gamma receptor 2,46337,124,1.94 [1.47-2.55],2.301968799313929e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IGF1R,Insulin-like growth factor 1 receptor,46483,124,3.00 [2.28-3.94],3.511070987897551e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IGF2R,Cation-independent mannose-6-phosphate receptor,46698,127,7.49 [4.45-12.60],3.5178696480590784e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IGFBP2,Insulin-like growth factor-binding protein 2,47191,127,1.86 [1.45-2.40],1.1781827846044243e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IGFBP3,Insulin-like growth factor-binding protein 3,46888,125,0.32 [0.23-0.44],7.057651631277951e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IGFBP4,Insulin-like growth factor-binding protein 4,46101,125,3.65 [3.06-4.35],3.0888051256546073e-47
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IGFBP6,Insulin-like growth factor-binding protein 6,46496,124,3.64 [2.68-4.96],2.0096438396038562e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IGFBP7,Insulin-like growth factor-binding protein 7,47267,128,2.29 [1.88-2.78],1.3240413682330566e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IGFBPL1,Insulin-like growth factor-binding protein-like 1,46694,125,5.02 [3.67-6.87],7.340394001634939e-24
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IGLC2,Immunoglobulin lambda constant 2,40613,105,2.42 [1.81-3.25],3.66875493539735e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IGSF3,Immunoglobulin superfamily member 3,46483,124,2.91 [2.38-3.55],7.41690856952447e-26
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IGSF8,Immunoglobulin superfamily member 8,46694,125,4.76 [3.61-6.27],1.429332837889519e-28
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IGSF9,Protein turtle homolog A,40628,107,1.76 [1.45-2.15],1.5087229220067817e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL10,Interleukin-10,45833,124,1.40 [1.22-1.61],2.981996772981469e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL10RB,Interleukin-10 receptor subunit beta,46900,124,3.76 [3.03-4.67],2.8062559670483655e-33
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL12A_IL12B,Interleukin-12,46483,124,2.14 [1.81-2.52],9.863784639451492e-20
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL12B,Interleukin-12 subunit beta,47210,127,2.62 [2.01-3.42],1.327069365549323e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL12RB1,Interleukin-12 receptor subunit beta-1,45833,124,2.97 [2.45-3.61],5.331553165014272e-28
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL12RB2,Interleukin-12 receptor subunit beta-2,39446,103,2.07 [1.48-2.89],2.013323199709141e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL15RA,Interleukin-15 receptor subunit alpha,45833,124,3.94 [2.57-6.03],2.9218277413464653e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL17C,Interleukin-17C,45833,124,1.63 [1.41-1.88],3.483136438623354e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL18,Interleukin-18,46512,123,2.59 [1.99-3.38],2.181058537376309e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL18BP,Interleukin-18-binding protein,46888,125,7.58 [5.41-10.63],7.151796456966101e-32
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL18R1,Interleukin-18 receptor 1,47210,127,8.36 [5.62-12.44],1.0183214637801551e-25
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL19,Interleukin-19,45516,120,1.75 [1.51-2.04],2.8438899316854725e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL1R1,Interleukin-1 receptor type 1,46618,126,3.11 [2.28-4.24],7.969439431386168e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL1R2,Interleukin-1 receptor type 2,46593,123,8.97 [4.06-19.83],5.921194146932245e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL1RL1,Interleukin-1 receptor-like 1,47110,128,3.14 [2.25-4.38],1.87057636718224e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL1RN,Interleukin-1 receptor antagonist protein,46595,124,2.12 [1.76-2.56],5.390352380578192e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL22,Interleukin-22,40433,105,1.58 [1.28-1.96],2.838528844991103e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL2RA,Interleukin-2 receptor subunit alpha,46359,127,2.78 [2.30-3.37],4.515125221800066e-26
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL4R,Interleukin-4 receptor subunit alpha,46626,123,3.15 [2.36-4.22],8.381342863670866e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL6,Interleukin-6,46483,124,1.54 [1.35-1.76],2.1201436350957887e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL6ST,Interleukin-6 receptor subunit beta,46694,125,5.04 [3.32-7.67],4.0954261138912285e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IMMT,MICOS complex subunit MIC60,40433,105,2.58 [2.09-3.20],2.958613510840329e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,INHBB,Inhibin beta B chain,39729,105,2.43 [1.79-3.29],1.0370368112263794e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,INHBC,Inhibin beta C chain,46698,127,4.43 [2.87-6.85],2.0752023664622624e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,INSL4,Early placenta insulin-like peptide,40433,105,1.60 [1.31-1.96],4.492692672624798e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,INSL5,Insulin-like peptide INSL5,40451,106,1.50 [1.27-1.79],3.1379350426730434e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,INSR,Insulin receptor,39446,103,7.21 [3.94-13.20],1.4789200979239114e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ITGA11,Integrin alpha-11,46626,123,0.39 [0.25-0.61],2.993286186919369e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ITGA5,Integrin alpha-5,46698,127,8.52 [4.89-14.82],3.5647431110741184e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ITGB2,Integrin beta-2,46408,124,3.69 [2.38-5.72],5.050806067219787e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ITGB6,Integrin beta-6,45833,124,3.21 [1.91-5.38],9.983676047927613e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ITGB7,Integrin beta-7,47097,128,2.45 [1.85-3.25],4.6867034634147e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ITGBL1,Integrin beta-like protein 1,40614,105,3.88 [3.05-4.95],5.689997570588507e-28
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,46888,125,4.41 [2.92-6.65],1.5844623309257632e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,JAM2,Junctional adhesion molecule B,47117,128,4.87 [3.38-7.02],2.3234309133590158e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,JAM3,Junctional adhesion molecule C,39729,105,1.97 [1.47-2.64],5.504178546005905e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,46483,124,2.30 [1.59-3.33],9.500990331929708e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KIF1C,Kinesin-like protein KIF1C,39283,102,1.99 [1.53-2.61],4.403994206363277e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KLK11,Kallikrein-11,46410,129,2.08 [1.67-2.60],1.0818495473322295e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KLK4,Kallikrein-4,47097,128,2.22 [1.95-2.52],1.7932568250431868e-33
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KLRB1,Killer cell lectin-like receptor subfamily B member 1,47210,127,8.20 [5.97-11.26],1.333153994354782e-38
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KLRD1,Natural killer cells antigen CD94,47210,127,2.81 [2.05-3.86],1.8245395411013847e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KLRF1,Killer cell lectin-like receptor subfamily F member 1,39446,103,1.78 [1.43-2.21],2.2793559660749097e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KLRK1,NKG2-D type II integral membrane protein,40529,106,2.39 [1.91-3.00],4.838729028422266e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KRT18,"Keratin, type I cytoskeletal 18",46483,124,1.70 [1.47-1.96],4.065430982241014e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KRT19,"Keratin, type I cytoskeletal 19",46552,123,2.54 [2.14-3.01],9.005060082654295e-27
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KRT8,"Keratin, type II cytoskeletal 8",39312,102,1.51 [1.36-1.67],1.697950432653306e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LAG3,Lymphocyte activation gene 3 protein,46483,124,2.81 [2.30-3.42],1.9097916026379423e-24
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,46670,123,3.60 [2.89-4.48],1.4764278011396181e-30
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LAMB1,Laminin subunit beta-1,39538,103,4.51 [2.43-8.39],1.872216215588384e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LAMP3,Lysosome-associated membrane glycoprotein 3,47133,127,1.85 [1.39-2.45],2.18873494218772e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LAYN,Layilin,46261,123,5.59 [4.37-7.16],9.43308298551583e-43
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LBP,Lipopolysaccharide-binding protein,46888,125,1.68 [1.30-2.16],5.923536707955925e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LCN15,Lipocalin-15,40550,105,1.72 [1.46-2.02],5.3630626284823164e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LCN2,Neutrophil gelatinase-associated lipocalin,45294,121,2.92 [2.21-3.87],7.363061974734869e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LEFTY2,Left-right determination factor 2,47029,128,1.82 [1.35-2.44],6.98258627702112e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LETM1,Mitochondrial proton/calcium exchanger protein,40550,105,1.96 [1.52-2.53],1.6767892865142157e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LGALS1,Galectin-1,46694,125,2.54 [1.76-3.67],6.630224375846387e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LGALS3,Galectin-3,46818,125,3.47 [2.22-5.41],4.144504199110501e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LGALS3BP,Galectin-3-binding protein,40679,105,2.82 [2.04-3.92],4.758489755043605e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LGALS4,Galectin-4,46670,123,4.38 [3.61-5.31],1.6875209928092685e-50
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LGALS9,Galectin-9,46668,124,7.16 [4.90-10.44],1.8008150991506418e-24
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LIFR,Leukemia inhibitory factor receptor,46626,123,8.06 [5.85-11.11],2.7601124697648205e-37
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,46621,125,3.70 [2.37-5.78],9.482802841449777e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,47267,128,3.96 [2.32-6.74],4.121643581136295e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,47034,127,3.12 [1.91-5.08],4.984976529411619e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,45833,124,3.20 [2.38-4.31],1.3397167183981604e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LMNB2,Lamin-B2,40529,106,3.53 [2.26-5.52],3.1798657078532937e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LMOD1,Leiomodin-1,40550,105,2.34 [1.82-3.01],4.421817056667995e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LPO,Lactoperoxidase,45152,122,2.21 [1.74-2.81],6.562643186904156e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,46960,128,3.11 [2.08-4.67],3.908206071579104e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LRP11,Low-density lipoprotein receptor-related protein 11,46694,125,4.86 [3.42-6.91],1.477465073253425e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LRRC25,Leucine-rich repeat-containing protein 25,46483,124,2.63 [1.93-3.58],7.810760870272344e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LRRN1,Leucine-rich repeat neuronal protein 1,45833,124,0.43 [0.29-0.63],1.562825438402015e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LTBP2,Latent-transforming growth factor beta-binding protein 2,47267,128,6.37 [4.60-8.82],7.557919395575054e-29
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LTBP3,Latent-transforming growth factor beta-binding protein 3,45615,120,1.81 [1.50-2.19],6.230826844570272e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LTBR,Tumor necrosis factor receptor superfamily member 3,46439,123,6.07 [4.29-8.60],3.1873365732052422e-24
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LY6D,Lymphocyte antigen 6D,46445,124,2.23 [1.66-2.98],7.48009411387674e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LY9,T-lymphocyte surface antigen Ly-9,46157,123,5.04 [3.32-7.65],2.852848339387423e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LY96,Lymphocyte antigen 96,46337,124,2.76 [2.04-3.73],4.757164642434757e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LYPD8,Ly6/PLAUR domain-containing protein 8,45615,120,1.62 [1.27-2.07],9.166390127819078e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,46186,123,1.56 [1.29-1.89],4.4604036023599024e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MAMDC2,MAM domain-containing protein 2,40628,107,3.19 [2.13-4.77],1.8931574788160138e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MANSC1,MANSC domain-containing protein 1,46850,129,5.22 [3.36-8.10],1.6465092179083913e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MAP2,Microtubule-associated protein 2,40529,106,1.83 [1.41-2.38],5.479085057652952e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MATN2,Matrilin-2,46745,123,2.98 [1.78-4.96],2.887666304977801e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MB,Myoglobin,47267,128,1.84 [1.48-2.29],3.899854205509765e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MCFD2,Multiple coagulation factor deficiency protein 2,46482,125,2.08 [1.49-2.90],1.6868942402871308e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,46337,124,1.62 [1.28-2.05],5.23766998161078e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MDK,Midkine,46705,129,2.04 [1.73-2.40],2.1448822630394817e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MENT,Protein MENT,39729,105,0.40 [0.28-0.57],4.425826563143482e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MFAP4,Microfibril-associated glycoprotein 4,39729,105,7.77 [4.52-13.34],1.111225821039832e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MFGE8,Lactadherin,46698,127,4.22 [3.18-5.59],1.2408352672624493e-23
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MILR1,Allergin-1,45833,124,2.52 [1.95-3.25],1.5541127470319698e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MLN,Promotilin,46626,123,1.78 [1.47-2.15],2.370913943551512e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MME,Neprilysin,46483,124,1.68 [1.40-2.01],1.5409273603367248e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MMP10,Stromelysin-2,46591,123,1.95 [1.56-2.43],3.5289959543589127e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MMP12,Macrophage metalloelastase,46734,128,2.65 [2.10-3.35],2.382023630483881e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MMP7,Matrilysin,45765,124,3.97 [2.92-5.40],1.7665986157359942e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MRC1,Macrophage mannose receptor 1,40646,105,8.51 [5.20-13.91],1.5012434242488386e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MSLN,Mesothelin,46414,124,1.83 [1.45-2.31],3.139049217136411e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MSR1,Macrophage scavenger receptor types I and II,47117,128,3.89 [2.96-5.11],2.4734007375807435e-22
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MUC13,Mucin-13,45638,124,4.74 [3.97-5.65],7.662676569544941e-67
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MVK,Mevalonate kinase,45833,124,1.66 [1.41-1.96],2.200507223254608e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MYBPC1,"Myosin-binding protein C, slow-type",40628,107,2.04 [1.69-2.46],1.1259627322780797e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MYL3,Myosin light chain 3,39538,103,1.93 [1.54-2.41],1.1944829726510464e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",39492,104,1.72 [1.40-2.12],4.00249739313813e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MYOM3,Myomesin-3,39729,105,1.47 [1.22-1.77],5.523230931151873e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MZB1,Marginal zone B- and B1-cell-specific protein,46822,123,1.92 [1.47-2.51],1.6273409584575738e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NBL1,Neuroblastoma suppressor of tumorigenicity 1,46850,129,10.15 [6.69-15.40],1.169631019766775e-27
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NCAN,Neurocan core protein,47117,128,0.47 [0.37-0.58],1.2255267771891388e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NCR1,Natural cytotoxicity triggering receptor 1,46558,123,4.78 [3.39-6.74],4.705123588882262e-19
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,40451,106,4.82 [3.37-6.90],7.527272500378581e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NCS1,Neuronal calcium sensor 1,47097,128,6.18 [3.83-9.98],9.454176606149446e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NECTIN2,Nectin-2,46621,125,8.44 [6.19-11.51],1.9410246338582188e-41
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NECTIN4,Nectin-4,46850,129,3.46 [2.69-4.45],4.254428976381277e-22
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NEFL,Neurofilament light polypeptide,45494,123,2.61 [2.13-3.19],7.809790174621492e-21
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NELL1,Protein kinase C-binding protein NELL1,46850,129,0.55 [0.44-0.68],9.850110182301224e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NFASC,Neurofascin,47210,127,25.61 [16.93-38.73],2.9832670430990063e-53
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",45833,124,1.78 [1.45-2.17],1.6332500418234033e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NGFR,Tumor necrosis factor receptor superfamily member 16,40628,107,2.32 [1.76-3.06],2.556767388195904e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NGRN,Neugrin,40529,106,3.32 [2.25-4.90],1.619517154812514e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NHLRC3,NHL repeat-containing protein 3,38778,103,7.02 [3.97-12.42],2.150596893142325e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NOMO1,Nodal modulator 1,46698,127,4.31 [2.60-7.16],1.6437781760884774e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NOS1,"Nitric oxide synthase, brain",45638,124,2.10 [1.74-2.53],1.448433993583731e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NOS3,"Nitric oxide synthase, endothelial",45638,124,1.74 [1.49-2.02],1.1695994720114137e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NOTCH1,Neurogenic locus notch homolog protein 1,47267,128,13.25 [5.66-31.05],2.7114133204385742e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NOTCH2,Neurogenic locus notch homolog protein 2,40614,105,3.96 [1.99-7.88],8.60126146540607e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NPDC1,Neural proliferation differentiation and control protein 1,46694,125,3.76 [2.96-4.78],2.038934283043845e-27
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NPPB,Natriuretic peptides B,45838,124,1.43 [1.28-1.59],3.074249078671678e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NPY,Pro-neuropeptide Y,47097,128,3.98 [3.02-5.26],1.5981024235940212e-22
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NRCAM,Neuronal cell adhesion molecule,46694,125,5.02 [3.57-7.06],1.920443284657624e-20
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NRP1,Neuropilin-1,46966,125,6.21 [3.72-10.35],2.806570860222499e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NT5C1A,Cytosolic 5'-nucleotidase 1A,40529,106,2.43 [1.97-2.98],3.9427948887399867e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NTF3,Neurotrophin-3,46626,123,2.62 [1.90-3.61],4.549337059385802e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NTproBNP,N-terminal prohormone of brain natriuretic peptide,46694,125,1.62 [1.45-1.80],1.3036765448612988e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NUCB2,Nucleobindin-2,47019,128,2.77 [1.92-4.00],5.3172782408920864e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,OCLN,Occludin,40550,105,3.16 [2.45-4.06],4.0887552657398e-19
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,OGN,Mimecan,46698,127,3.23 [2.44-4.27],3.209577984436487e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,OLFM4,Olfactomedin-4,38252,100,1.40 [1.18-1.66],8.7875656724896e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,OMD,Osteomodulin,46900,124,0.33 [0.24-0.46],3.475106015837533e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,OMG,Oligodendrocyte-myelin glycoprotein,46483,124,0.61 [0.49-0.77],2.3624936981213944e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,OSCAR,Osteoclast-associated immunoglobulin-like receptor,46745,123,4.22 [2.67-6.65],6.428464506786882e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,OSMR,Oncostatin-M-specific receptor subunit beta,46966,125,6.69 [3.14-14.28],8.605179274467746e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,OXT,Oxytocin-neurophysin 1,47117,128,1.27 [1.14-1.42],3.092508997215965e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,45838,124,1.63 [1.28-2.08],6.536673121842532e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PALM,Paralemmin-1,40232,106,3.23 [2.43-4.31],1.112932897504835e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PALM2,Paralemmin-2,40529,106,3.83 [3.02-4.85],1.1012008313622098e-28
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PCDH17,Protocadherin-17,46694,125,3.25 [2.56-4.12],3.3879589405428123e-22
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PCDH7,Protocadherin-7,40451,106,1.84 [1.36-2.50],7.992055748947328e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PCSK9,Proprotein convertase subtilisin/kexin type 9,47267,128,2.70 [1.86-3.90],1.3800088631941462e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PDCD1,Programmed cell death protein 1,47019,128,2.60 [2.03-3.33],3.3502466102499134e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PDCD1LG2,Programmed cell death 1 ligand 2,46483,124,3.14 [2.42-4.07],6.234650481751248e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PDGFRA,Platelet-derived growth factor receptor alpha,46694,125,5.58 [3.66-8.51],1.3589371465681433e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PDIA3,Protein disulfide-isomerase A3,39729,105,2.71 [1.93-3.80],9.872371620775025e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,39446,103,2.56 [1.97-3.33],1.637539076953943e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PENK,Proenkephalin-A,39729,105,2.54 [1.88-3.43],1.3719889496753174e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PGF,Placenta growth factor,47210,127,4.24 [3.38-5.33],2.0610349743641127e-35
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PGLYRP1,Peptidoglycan recognition protein 1,47034,127,2.31 [1.75-3.05],4.091365854942395e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PHLDB1,Pleckstrin homology-like domain family B member 1,40451,106,2.14 [1.57-2.92],1.722906179143217e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,46337,124,4.09 [3.03-5.51],2.6600874170044602e-20
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PI3,Elafin,46066,125,2.03 [1.69-2.45],1.087587187688356e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PIGR,Polymeric immunoglobulin receptor,46097,126,6.08 [4.61-8.03],2.346642962301514e-37
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PILRA,Paired immunoglobulin-like type 2 receptor alpha,46698,127,4.79 [3.49-6.58],3.750341508821386e-22
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PILRB,Paired immunoglobulin-like type 2 receptor beta,46694,125,3.36 [2.43-4.64],1.8254712391792565e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PKD1,Polycystin-1,40628,107,12.81 [6.92-23.73],5.157439945907432e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PKD2,Polycystin-2,39283,102,1.68 [1.31-2.14],3.1870423389560144e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PLA2G10,Group 10 secretory phospholipase A2,46337,124,1.83 [1.39-2.39],1.1512217911358087e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PLA2G15,Phospholipase A2 group XV,46850,129,5.51 [3.41-8.92],3.402351349935612e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PLA2G7,Platelet-activating factor acetylhydrolase,46698,127,0.54 [0.41-0.71],8.869605985752493e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PLAUR,Urokinase plasminogen activator surface receptor,46358,123,12.99 [8.83-19.11],8.283974976239528e-39
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PLIN3,Perilipin-3,46694,125,1.98 [1.43-2.74],3.634793459222728e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PLXDC2,Plexin domain-containing protein 2,40529,106,2.17 [1.53-3.07],1.3225798694898374e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PLXNB2,Plexin-B2,47037,127,33.26 [22.94-48.23],2.6459956311575407e-76
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,POF1B,Protein POF1B,39446,103,2.23 [1.84-2.70],3.210635065608566e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",46483,124,1.75 [1.33-2.31],6.881510057414334e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PON1,Serum paraoxonase/arylesterase 1,40646,105,0.38 [0.27-0.54],6.18547047045955e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PON3,Serum paraoxonase/lactonase 3,46900,124,0.39 [0.33-0.45],3.935704482505396e-36
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,40550,105,2.02 [1.48-2.75],8.174491625066359e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PPY,Pancreatic prohormone,46639,129,1.58 [1.37-1.82],2.9379385686829343e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PRAP1,Proline-rich acidic protein 1,40614,105,23.78 [14.52-38.93],2.197352500718132e-36
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PRCP,Lysosomal Pro-X carboxypeptidase,46970,128,4.48 [3.57-5.63],3.415543350207201e-38
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PRDX2,Peroxiredoxin-2,39951,102,0.51 [0.37-0.72],9.656732210725592e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PRDX6,Peroxiredoxin-6,47097,128,0.54 [0.41-0.71],8.645088326219319e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PREB,Prolactin regulatory element-binding protein,45833,124,2.34 [1.73-3.18],4.909774762509049e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PRELP,Prolargin,46670,123,4.45 [2.87-6.89],2.310431770484852e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PRG2,Bone marrow proteoglycan,40614,105,2.39 [1.73-3.29],1.1447375710924136e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PRRT3,Proline-rich transmembrane protein 3,39538,103,2.57 [1.64-4.03],4.2137373593053344e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PRSS22,Brain-specific serine protease 4,39446,103,2.09 [1.71-2.54],3.287217135643275e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PRSS8,Prostasin,46516,124,6.77 [5.06-9.06],7.698250702119092e-38
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PRTG,Protogenin,47097,128,3.46 [2.35-5.09],2.7012711116691747e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PSAP,Prosaposin,40226,105,2.99 [2.28-3.92],3.258637106559498e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PSG1,Pregnancy-specific beta-1-glycoprotein 1,46337,124,1.87 [1.56-2.25],2.132103798382457e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PTGDS,Prostaglandin-H2 D-isomerase,46354,124,5.02 [3.77-6.67],1.9530126776726422e-28
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,46626,123,1.71 [1.34-2.18],1.4397577518201584e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PTK7,Inactive tyrosine-protein kinase 7,45638,124,2.62 [1.86-3.71],4.216303098127329e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PTPRB,Receptor-type tyrosine-protein phosphatase beta,40628,107,3.03 [1.84-4.99],1.248362498751418e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PTPRC,Receptor-type tyrosine-protein phosphatase C,40614,105,3.94 [2.38-6.50],8.946986800472503e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PTPRN2,Receptor-type tyrosine-protein phosphatase N2,46183,123,2.79 [1.92-4.06],8.435887706500926e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PVR,Poliovirus receptor,47117,128,4.02 [2.96-5.44],2.640282292755113e-19
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PYY,Peptide YY,39283,102,2.33 [2.00-2.71],2.0756580599744118e-27
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,QPCT,Glutaminyl-peptide cyclotransferase,46737,127,5.88 [3.93-8.80],6.270546323108205e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,QSOX1,Sulfhydryl oxidase 1,39866,103,1.72 [1.39-2.12],4.852408209210949e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RAB6A,Ras-related protein Rab-6A,46626,123,0.42 [0.30-0.59],3.480096856123412e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RARRES2,Retinoic acid receptor responder protein 2,46966,125,2.05 [1.66-2.53],2.339478526779312e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RBFOX3,RNA binding protein fox-1 homolog 3,40550,105,3.71 [2.23-6.18],4.667376473672385e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RBP2,Retinol-binding protein 2,46483,124,1.74 [1.45-2.10],5.4070991007311294e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RBP5,Retinol-binding protein 5,46483,124,2.52 [2.01-3.14],4.530359704704054e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RBP7,Retinoid-binding protein 7,40451,106,1.68 [1.34-2.10],6.0291581813159954e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,REG1A,Lithostathine-1-alpha,46424,123,3.24 [2.71-3.86],1.2542035115122932e-38
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,REG1B,Lithostathine-1-beta,47267,128,2.40 [2.00-2.87],1.305863987806327e-21
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,REG3A,Regenerating islet-derived protein 3-alpha,47267,128,2.27 [1.88-2.73],6.030473426372343e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,REG4,Regenerating islet-derived protein 4,46745,123,5.17 [4.10-6.53],9.533572665580473e-44
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RELT,Tumor necrosis factor receptor superfamily member 19L,46698,127,4.52 [3.26-6.28],2.1611219962627825e-19
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,REN,Renin,46694,125,2.56 [2.27-2.89],3.242012573840291e-52
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RETN,Resistin,46576,124,2.45 [1.89-3.17],1.234957625944916e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RGMB,RGM domain family member B,47117,128,2.81 [1.69-4.68],7.08646649783495e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RNASE1,Ribonuclease pancreatic,40646,105,4.30 [3.44-5.39],4.364440245035702e-37
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RNASE10,Inactive ribonuclease-like protein 10,39538,103,1.98 [1.60-2.44],2.0703583510240167e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RNASE4,Ribonuclease 4,39311,100,4.27 [3.05-5.99],4.119576095427857e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RNASE6,Ribonuclease K6,40361,104,2.52 [2.13-2.98],1.337804849510304e-27
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RNASET2,Ribonuclease T2,47038,128,7.01 [5.26-9.34],2.5467189201114833e-40
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RNF149,E3 ubiquitin-protein ligase RNF149,39538,103,3.73 [2.99-4.64],9.96932658908504e-32
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ROBO1,Roundabout homolog 1,46745,123,5.02 [3.33-7.58],1.5794433258351718e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,46694,125,2.62 [1.65-4.17],4.3597202602580176e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RSPO3,R-spondin-3,47097,128,3.57 [2.38-5.35],7.211360887369362e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RTN4R,Reticulon-4 receptor,47097,128,3.75 [3.14-4.47],3.855917092859859e-49
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SCARA5,Scavenger receptor class A member 5,47117,128,7.55 [5.27-10.83],4.065330474664746e-28
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SCARB2,Lysosome membrane protein 2,45454,123,4.56 [3.69-5.63],8.540377277955587e-45
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SCARF1,Scavenger receptor class F member 1,47267,128,2.50 [1.78-3.51],1.055665103406582e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SCARF2,Scavenger receptor class F member 2,47117,128,7.11 [4.75-10.63],1.3350024715809618e-21
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SCG2,Secretogranin-2,46882,128,9.81 [6.70-14.36],7.321161813845182e-32
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SCGN,Secretagogin,45833,124,3.09 [2.39-3.99],8.49178609553001e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SCN4B,Sodium channel subunit beta-4,39538,103,2.25 [1.50-3.37],9.01265157559116e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SCRG1,Scrapie-responsive protein 1,40628,107,2.61 [1.80-3.80],4.973485072495251e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SDC1,Syndecan-1,46694,125,2.70 [2.03-3.60],8.833211217222106e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SEL1L,Protein sel-1 homolog 1,39538,103,1.74 [1.41-2.15],2.9085804246192935e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SELE,E-selectin,47267,128,2.56 [1.88-3.49],2.073318206846169e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SEMA3F,Semaphorin-3F,46694,125,5.81 [3.36-10.05],2.859834838809696e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SEMA7A,Semaphorin-7A,47110,128,3.70 [2.90-4.73],8.999516508095154e-26
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SEPTIN8,Septin-8,40452,106,3.25 [2.41-4.38],9.473812572847786e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SERPINA6,Corticosteroid-binding globulin,40679,105,7.79 [2.78-21.86],9.597233954250966e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SERPINA9,Serpin A9,46259,123,1.68 [1.39-2.03],6.232356515053253e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SERPINF1,Pigment epithelium-derived factor,40063,103,5.78 [3.65-9.16],8.420729300534589e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SEZ6L,Seizure 6-like protein,46850,129,2.79 [1.67-4.66],8.454350165430061e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SFRP1,Secreted frizzled-related protein 1,46180,124,1.87 [1.48-2.36],1.5351754518474834e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SHBG,Sex hormone-binding globulin,40646,105,0.51 [0.37-0.70],4.210784042476123e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SHISA5,Protein shisa-5,40614,105,3.94 [3.22-4.83],2.45532145891206e-40
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SIGLEC1,Sialoadhesin,46900,124,3.93 [3.06-5.05],9.265345432444366e-27
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SIGLEC10,Sialic acid-binding Ig-like lectin 10,46626,123,3.18 [2.62-3.84],1.6775734302987308e-32
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SIGLEC5,Sialic acid-binding Ig-like lectin 5,46698,127,1.49 [1.23-1.79],3.226013850059104e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SIGLEC6,Sialic acid-binding Ig-like lectin 6,47097,128,3.82 [2.86-5.11],1.4904591030689765e-19
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SIGLEC7,Sialic acid-binding Ig-like lectin 7,46694,125,5.04 [3.20-7.95],3.0353804411212e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SIGLEC8,Sialic acid-binding Ig-like lectin 8,39538,103,2.86 [1.95-4.20],8.6546452179432e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SIGLEC9,Sialic acid-binding Ig-like lectin 9,47028,128,2.80 [1.68-4.66],7.824375972750171e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,46815,125,2.26 [1.61-3.19],2.773733248043433e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SIRPB1,Signal-regulatory protein beta-1,46594,123,3.72 [2.82-4.90],9.458379489028583e-21
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SIT1,Signaling threshold-regulating transmembrane adapter 1,45833,124,1.93 [1.47-2.54],2.250879379663376e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SLAMF1,Signaling lymphocytic activation molecule,45833,124,2.30 [1.84-2.87],2.58029978789988e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SLAMF6,SLAM family member 6,45615,120,2.73 [2.08-3.57],3.837177810321533e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SLAMF7,SLAM family member 7,46626,123,2.05 [1.65-2.54],8.770887553536166e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SLAMF8,SLAM family member 8,45615,120,3.47 [2.67-4.51],1.3778953044383376e-20
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SLC39A5,Zinc transporter ZIP5,46626,123,1.60 [1.29-1.98],1.609685383820824e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SLITRK2,SLIT and NTRK-like protein 2,47097,128,2.30 [1.58-3.35],1.316483582391399e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SLMAP,Sarcolemmal membrane-associated protein,40451,106,1.59 [1.31-1.92],2.7193004811268007e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SMOC1,SPARC-related modular calcium-binding protein 1,47097,128,3.34 [2.52-4.41],2.855080423844269e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SMOC2,SPARC-related modular calcium-binding protein 2,46900,124,3.08 [2.26-4.21],1.471680073946873e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SMPD1,Sphingomyelin phosphodiesterase,46888,125,2.14 [1.61-2.83],1.3889552480577066e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SMTN,Smoothelin,40451,106,1.43 [1.21-1.70],3.770338334231046e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SNCG,Gamma-synuclein,46337,124,2.38 [1.90-2.97],2.325327866973604e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",39538,103,2.10 [1.45-3.06],9.359452893474512e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SORBS1,Sorbin and SH3 domain-containing protein 1,40550,105,1.79 [1.45-2.22],7.278100384144366e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SORCS2,VPS10 domain-containing receptor SorCS2,45615,120,4.58 [3.38-6.20],9.082237553357108e-23
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SPINK1,Serine protease inhibitor Kazal-type 1,46698,127,4.06 [3.30-4.99],5.514794649644349e-40
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SPINK4,Serine protease inhibitor Kazal-type 4,46626,123,2.90 [2.50-3.35],3.477685322027541e-46
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SPINT1,Kunitz-type protease inhibitor 1,46543,126,3.96 [2.82-5.55],1.8274676604863285e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SPINT2,Kunitz-type protease inhibitor 2,46900,124,3.63 [2.54-5.19],1.492392495198946e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SPON1,Spondin-1,46745,123,3.42 [2.83-4.13],5.225857399544051e-37
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SPON2,Spondin-2,46468,125,6.72 [4.66-9.70],2.3132708986205488e-24
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SRPX,Sushi repeat-containing protein SRPX,40628,107,2.81 [1.75-4.52],2.0289404203812512e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",46483,124,1.84 [1.42-2.37],2.839229194726575e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",47267,128,2.72 [2.10-3.51],2.0776895015810683e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,STAB2,Stabilin-2,40614,105,3.21 [1.78-5.77],9.919924974762224e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,STC1,Stanniocalcin-1,47117,128,2.51 [1.93-3.26],4.427475679426792e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,STC2,Stanniocalcin-2,46637,127,4.56 [2.44-8.53],2.00805841578198e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,STX4,Syntaxin-4,46483,124,1.48 [1.22-1.79],5.912184300320737e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SULT2A1,Bile salt sulfotransferase,46626,123,1.56 [1.29-1.89],4.885319281883126e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SUSD2,Sushi domain-containing protein 2,46698,127,2.54 [1.69-3.84],8.512400203088795e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TACSTD2,Tumor-associated calcium signal transducer 2,41390,114,2.90 [2.17-3.86],4.1430315943239123e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TAFA5,Chemokine-like protein TAFA-5,46483,124,3.04 [2.23-4.14],2.3323984530619152e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TCL1A,T-cell leukemia/lymphoma protein 1A,46265,124,0.71 [0.61-0.82],6.229891156161402e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TCN2,Transcobalamin-2,47191,127,3.66 [2.77-4.84],7.227464565882062e-20
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TCOF1,Treacle protein,40628,107,2.16 [1.55-3.00],5.378033023092746e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TEK,Angiopoietin-1 receptor,46850,129,4.57 [2.35-8.88],7.345972296872397e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TFF1,Trefoil factor 1,46468,127,2.12 [1.84-2.44],7.730495664436878e-25
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TFF2,Trefoil factor 2,46823,124,3.61 [2.94-4.42],5.009917292294216e-35
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TFF3,Trefoil factor 3,46671,125,2.52 [2.21-2.87],2.3504508954560987e-43
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TFPI2,Tissue factor pathway inhibitor 2,46703,129,1.54 [1.26-1.88],2.2006884551169327e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TFRC,Transferrin receptor protein 1,46889,125,2.26 [1.61-3.17],2.563347684140013e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TGFA,Protransforming growth factor alpha,46626,123,2.86 [2.24-3.64],2.4360451165269934e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TGFB1,Transforming growth factor beta-1 proprotein,47133,127,2.66 [2.07-3.41],2.126980561162624e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TGFBR1,TGF-beta receptor type-1,39446,103,2.56 [1.70-3.85],6.047707965862239e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TGFBR2,TGF-beta receptor type-2,46850,129,3.97 [3.17-4.96],1.1751895057134752e-33
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TGOLN2,Trans-Golgi network integral membrane protein 2,40646,105,5.08 [2.87-8.99],2.348003664083369e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,THBD,Thrombomodulin,46694,125,4.01 [2.87-5.60],3.8303753612966574e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,THBS2,Thrombospondin-2,46698,127,4.17 [3.31-5.27],2.204415320635912e-33
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,THY1,Thy-1 membrane glycoprotein,47117,128,3.72 [2.39-5.81],6.359265273873605e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TIGIT,T-cell immunoreceptor with Ig and ITIM domains,39882,107,2.37 [1.78-3.16],3.4046214648568597e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TIMP1,Metalloproteinase inhibitor 1,46208,125,5.61 [4.30-7.32],5.40986567741736e-37
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TINAGL1,Tubulointerstitial nephritis antigen-like,46544,125,6.52 [3.34-12.75],4.0524498684460537e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TLR1,Toll-like receptor 1,39446,103,4.01 [2.47-6.50],1.9003466710810195e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TMPRSS11D,Transmembrane protease serine 11D,40452,106,2.06 [1.46-2.89],3.173684751702711e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TMPRSS15,Enteropeptidase,46483,124,1.86 [1.56-2.22],5.405282937865492e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TNF,Tumor necrosis factor,45764,123,1.91 [1.58-2.31],2.988141429972154e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,46337,124,3.65 [3.05-4.36],9.306712372430582e-46
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,46337,124,20.80 [8.03-53.90],4.139852312164327e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,47210,127,5.27 [4.16-6.69],7.531153046206237e-43
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,46670,123,6.12 [4.41-8.50],2.31856226664372e-27
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,46850,129,5.59 [4.45-7.04],4.2762470858904015e-49
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,46745,123,2.43 [2.01-2.93],3.6165407800667934e-20
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,46745,123,7.46 [5.49-10.13],7.342215424044746e-38
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,47097,128,3.81 [2.89-5.03],3.846258785461235e-21
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,46698,127,7.07 [5.44-9.20],2.240241999527533e-48
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,46698,127,2.23 [1.95-2.55],6.22432594718474e-32
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,47117,128,4.26 [2.87-6.31],5.222802918406381e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,47133,127,4.14 [3.24-5.29],1.0499865843381182e-29
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,46337,124,2.11 [1.76-2.52],2.875213957396122e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,47117,128,2.47 [1.89-3.22],2.5799913002922328e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,46337,124,2.51 [2.15-2.93],2.2865178929852064e-31
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TNFSF12,Tumor necrosis factor ligand superfamily member 12,47210,127,0.31 [0.18-0.53],1.5702906441617606e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TNFSF13,Tumor necrosis factor ligand superfamily member 13,46900,124,5.91 [3.73-9.38],4.398274268135295e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TNFSF8,Tumor necrosis factor ligand superfamily member 8,40614,105,3.52 [2.48-4.99],1.9523878616627986e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TNN,Tenascin-N,40614,105,2.32 [1.52-3.54],9.096059094364352e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TPP1,Tripeptidyl-peptidase 1,46359,123,1.97 [1.55-2.52],5.2129115527836016e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TREH,Trehalase,40614,105,1.78 [1.36-2.32],2.8604271792483592e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TREM2,Triggering receptor expressed on myeloid cells 2,46670,123,2.30 [1.79-2.96],7.353550209291712e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TXNDC5,Thioredoxin domain-containing protein 5,47117,128,1.53 [1.24-1.89],8.078910319589946e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ULBP2,UL16-binding protein 2,46337,124,4.26 [3.24-5.59],2.621435036547129e-25
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,UMOD,Uromodulin,47123,127,0.35 [0.28-0.43],1.476468708978806e-23
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,USP28,Ubiquitin carboxyl-terminal hydrolase 28,40529,106,1.91 [1.45-2.53],5.462025165110438e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,VCAM1,Vascular cell adhesion protein 1,46810,125,7.47 [5.22-10.69],3.427636042857334e-28
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,VEGFA,Vascular endothelial growth factor A,47060,127,1.81 [1.43-2.30],1.1635837450052776e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,VEGFB,Vascular endothelial growth factor B,39446,103,4.74 [2.78-8.10],1.1841625361248325e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,VEGFD,Vascular endothelial growth factor D,47136,127,4.44 [3.04-6.48],1.1937083294367418e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,VMO1,Vitelline membrane outer layer protein 1 homolog,46483,124,1.97 [1.53-2.53],1.2118257139848126e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,VSIG2,V-set and immunoglobulin domain-containing protein 2,40433,105,2.72 [2.25-3.30],1.3354440395073432e-24
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,VSIG4,V-set and immunoglobulin domain-containing protein 4,46637,127,4.99 [3.95-6.30],3.023807196905699e-41
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,VWC2,Brorin,46182,123,3.09 [2.15-4.44],1.2209882404652014e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,VWF,von Willebrand factor,47267,128,1.53 [1.24-1.88],5.7440526913156525e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,WFDC1,WAP four-disulfide core domain protein 1,39616,104,1.62 [1.35-1.95],1.6061466720632925e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,WFDC2,WAP four-disulfide core domain protein 2,44329,123,3.63 [2.98-4.43],2.2493352838036763e-37
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",46184,124,0.35 [0.24-0.52],7.593737239105597e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,WIF1,Wnt inhibitory factor 1,47097,128,0.31 [0.19-0.50],1.3937612455034468e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,WNT9A,Protein Wnt-9a,45833,124,3.86 [2.93-5.08],6.71364088512291e-22
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,XCL1,Lymphotactin,47097,128,1.71 [1.41-2.08],6.86465977762911e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,XG,Glycoprotein Xg,47042,128,3.46 [2.57-4.67],3.692390818685171e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,XPNPEP2,Xaa-Pro aminopeptidase 2,46850,129,0.72 [0.63-0.82],1.481910461976734e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,YAP1,Transcriptional coactivator YAP1,40529,106,4.63 [3.55-6.05],2.6852223754858746e-29
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ZNRD2,Protein ZNRD2,40451,106,1.93 [1.55-2.40],4.610526896263596e-09
